Log inSupport Us
opengovt
Lobbying
← Back
Lobbying · Company

AstraZeneca

Meetings with ministers

69

In the last 12 months

13

Different ministers

26

Lobbying firms used

3

Meetings with ministers

DateMinisterPurpose, as published
13 May 2026Yvette CooperFCDOTo discuss the UK's economic relationship with China.
4 March 2026Wes StreetingDHSCTo discuss medicines pricing
4 March 2026Dr Zubir AhmedDHSCTo discuss medicines pricing
4 March 2026Sir Keir StarmerPrime MinisterVideo meeting to discuss UK competitiveness and investment opportunities in the pharmaceutical and life sciences sectors
27 February 2026Jason StockwoodDBTTo discuss the UK life sciences investment environment during a visit to their Macclesfield facility
10 February 2026Dr Zubir AhmedDHSCTo discuss life sciences priorities
30 January 2026Sir Keir StarmerPrime MinisterDrop-in to Life Sciences Roundtable for brushby introductions
2 December 2025Sir Keir StarmerPrime MinisterAudio call to discuss the UK as a commercial environment for the life sciences sector
17 November 2025Peter KyleDBTA fireside chat to discuss international trade and collaboration with the EU
4 November 2025Peter KyleDBTThe discuss the UK's business and investment environment
22 October 2025Dr Zubir AhmedDHSCTo discuss life sciences and the UK commercial environment
22 October 2025Wes StreetingDHSCTo discuss life sciences and medicines
22 October 2025Patrick VallanceDSITTo discuss Oxford to Cambridge Growth Corridor
1 October 2025Jason StockwoodDBTTo discuss the UK life sciences commercial environment
23 September 2025Chris BryantDBTTo discuss UK-Brazilian trade
19 September 2025Rachel ReevesHMTMeeting to discuss UK investment and the Pharmaceutical industry
19 September 2025Sir Keir StarmerPrime MinisterTo discuss the UK and global economy, including opportunities for the life sciences sector.
8 September 2025Patrick VallanceDSITQuarterly roundtable to discuss engineering biology in the UK
3 September 2025David LammyFCDOTo engage with high level UK businesses to build upon UK growth opportunities.
1 September 2025Sarah JonesDBTDiscussed the implementation of the Industrial Strategy
28 August 2025Patrick VallanceDSITTo discuss the life sciences sector
19 August 2025Lord LivermoreHMTTo discuss the challenges for the UK’s life sciences sector
26 June 2025Patrick VallanceDSITTo discuss the pharmaceutical landscape in the UK
24 June 2025Douglas AlexanderDBTTo discuss the Trade Strategy
24 June 2025Patrick VallanceDSITTo discuss the pharmaceutical landscape in the UK
16 June 2025Patrick VallanceDSITTo include various topics with inward investors including clinical trials, regulatory alignment and scientific collaboration.
10 June 2025Feryal ClarkDSITTo discuss AI opportunities in the life science sector.
2 June 2025Patrick VallanceDSITTo discuss the pharmaceutical landscape in the UK
14 May 2025Ashley DaltonDHSCTo engage with vaccines stakeholders on vaccine delivery
7 May 2025Patrick VallanceDSITTo discuss the pharmaceutical landscape in the UK
22 April 2025Patrick VallanceDSITQuarterly AstraZeneca board meeting to discuss the life sciences sector in the UK and the innovation ecosystem.
3 April 2025Sir Keir StarmerPrime MinisterBusiness roundtable to discuss UK-US trade talks with British businesses
2 April 2025Rachel ReevesHMTMeeting to discuss investment ahead of the Biopharmaceutical CEO Roundtable
2 April 2025Sir Keir StarmerPrime MinisterBiopharmaceuticals CEOs Roundtable to discuss global health challenges and life sciences policy
2 April 2025Peter KyleDSITRoundtable discuss issues facing life sciences in the UK, including VPAG, clincial trials, and health data
2 April 2025Patrick VallanceDSITBiopharmaceutical CEO Roundtable (BCR) Ministerial Policy Roundtable
31 March 2025Spencer LivermoreHMTTo discuss the life sciences in the growth mission, life sciences sector plan, VPAG and barriers to investment
31 March 2025Justin MaddersDBTTo participate in a panel discussion on Government's plan to Make Work Pay and the Employment Rights Bill
27 March 2025Sarah JonesDBTDiscussed the life sciences sector and the Industrial Strategy
27 March 2025Patrick VallanceDSITTo discuss company views on the industrial strategy
26 March 2025Douglas AlexanderDBTTo engage with UK businesses with Polish presence on UK-Poland trade and UK business footprint in Poland
20 March 2025Jonathan ReynoldsDBTTo discuss trade policy
27 February 2025Miatta FahnbullehDESNZDiscussion as part of a site visit on the potential of AstraZeneca's and Future Biogas' new biomethane plant
27 February 2025Patrick VallanceDSITGrowing Innovative Science and Technology Companies
10 February 2025Patrick VallanceDSITTo discuss the OxCam Growth Corridor and the Minister's new role as its champion.
27 January 2025Peter KyleDSITEvent to discuss the Oxford-Cambridge Arc, and the actions Government can take to support economic growth in the area, eg. the development of infrastructure
27 January 2025Patrick VallanceDSITTo discuss OxCam Supercluster report
20 January 2025Patrick VallanceDSITTo discuss growing innovative science and technology companies
20 January 2025Maggie JonesDSITTo discuss growing innovative science and technology companies
17 December 2024Patrick VallanceDSITTo discuss growing innovative science and tech companies
10 December 2024Poppy GustafssonDBTTo discuss AstraZeneca's UK investment plans
3 December 2024Jonathan ReynoldsDBTTo discuss growth agenda and business engagement
5 November 2024Wes StreetingDHSCTo discuss life sciences and medicines access
30 October 2024Peter KyleDSITTo discuss the Budget announcement.
23 October 2024Jonathan ReynoldsDBTRoundtable event with UK businesses based in Brazil to discuss opportunities for UK export opportunities.
22 October 2024Wes StreetingDHSCTo discuss life sciences at the Life Sciences Council
22 October 2024Patrick VallanceDSITMeeting of the Life Sciences Council.
22 October 2024Peter KyleDSITTo discuss AstraZeneca's footprint in the UK and key issues facing the life sciences sector.
22 October 2024Peter KyleDSITTo discuss priorities for the life sciences council and key issues for the sector.
22 October 2024Gillian MerronDHSCto discuss life sciences
22 October 2024Wes StreetingDHSCTo discuss life sciences and the UK's investment environment
15 October 2024Mary CreaghDefraTo discuss perspecties on the use of Digital Sequencing Information on genetic resources, ahead of the Convention on Biological Diversity.
7 October 2024Keir StarmerPrime MinisterMeeting to discuss the UK-AstraZeneca partnership and future investments in the UK's life sciences sector
7 October 2024Rachel ReevesHMTThe UK-Astra Zeneca partnership and future investments in the UK’s life sciences sector.
19 September 2024Patrick VallanceDSITTo discuss AstraZeneca's work in the UK
18 September 2024Douglas AlexanderDBTA meeting with British businesses operating in Thailand to discuss opportunities and challenges and area where HMG can provide more support
12 September 2024Matthew PennycookMHCLGTo discuss the Cambridge economy
5 September 2024Patrick VallanceDSITTo discuss alternatives to the use of animals in science
18 July 2024James MurrayHMT ministerial meetings July to September 2024Keynote speaker at CBI Business Leaders' Roundtable

Consultant lobbying firms

  • Incisive Health Ltd
    April to June 2026; January to March 2026; April to June 2025; January to March 2025
  • FTI Consulting LLP
    January to March 2025; October to December 2024; July to September 2024; April to June 2024
  • Hanover Communications International Limited
    October to December 2024; July to September 2024
About these records. Each row is one entry in a minister’s published meetings return, so a meeting with two ministers appears once for each. Dates and purposes are shown as the department published them. Published under these names too: “Astrazeneca”, “AstraZeneca plc”. Sources: GOV.UK ministers’ meetings transparency returns and the Registrar of Consultant Lobbyists quarterly returns, both under the Open Government Licence v3.0.